Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 10, 2000, Pages 1454-1456

  Mai, K T ^a   Isotalo, P A ^a   Green, J ^a   Perkins, D G ^a   Morash, C ^a   Collins, J P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;

ADENOMA; ARTICLE; CANCER SCREENING; CANCER STAGING; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRECANCER; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0033794674     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence - Data from the Utah Cancer Registry
2. Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen
3. Prostate cancer trends in Canada: Rising incidence or increased detection?
4. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: Epidemiologic significance of annual changes
5. Premalignant lesions
6. Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma
7. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors
8. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread
9. Zonal origin of prostatic adenocarcinoma: Are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland?
10. Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread
11. Impalpable invisible stage T1c prostate cancer: Characteristics and clinical relevance in 100 radical prostatectomy specimens - A different view
12. The pathology of incidental carcinoma
13. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate
14. Relationship between clinical stage and histological zone of origin in early prostate cancer: Morphometric analysis
15. Capsular penetration in prostate cancer. Significance for natural history and treatment
16. Numerical chromosomal aberrations in transition-zone carcinomas of the prostate
17. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate
18. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship with carcinoma in radical prostatectomy specimens
19. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies
20. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update
21. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens
22. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer
23. Incidental prostate cancer: Volume, location and degree of differentiation of the tumor in the radical prostatectomy specimen and value of subclassification to stage A1 and A2
24. Transurethral-resection zone prostate cancer detected at cystoprostatectomy. A detailed histologic analysis and clinical implications
25. Predictors of cancer progression in T1a prostate adenocarcinoma
26. Long-term follow-up of untreated stage T1a prostate cancer